Non-Applicability of Statement of Deviation or variation under Reg. 32 (1) of SEBI (LODR) Regulations, 2015
3BBLACKBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
3B BlackBio Dx Ltd (formerly Kilpest India Limited) has informed BSE that Regulation 32(1) of SEBI (LODR) does not apply to the company for the quarter and year ended 31st March 2025. The regulation requires companies that raise funds through public issues, rights issues, preferential issues, or qualified institutional placements (QIPs) to file a statement of deviation or variation in the use of such funds. The company has confirmed that it did not raise any funds through any of these routes during the period. As a result, no deviation or variation statement is required to be filed. The letter is signed by Nikhil Kuber Dubey, Whole Time Director.
This is a routine compliance disclosure with no material impact on the stock price or shareholders. It simply confirms that no fund-raising activity took place, so no deviation reporting is required.